Richard Malamut's most recent trade in Collegium Pharmaceutical Inc was a trade of 36,750 Common Stock done . Disclosure was reported to the exchange on Feb. 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 36,750 | 130,308 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,256 | 136,564 (0%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 4,462 | 132,102 (0%) | 0% | 17.6 | 78,665 | Common Stock |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 1,838 | 130,264 (0%) | 0% | 17.6 | 32,404 | Common Stock |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.38 per share. | 01 Apr 2021 | 3,119 | 93,558 (0%) | 0% | 23.4 | 72,922 | Common Stock |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 1,542 | 96,677 (0%) | 0% | 26.0 | 40,015 | Common Stock |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 758 | 98,219 (0%) | 0% | 25.9 | 19,670 | Common Stock |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 36,960 | 96,790 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Richard Malamut | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 2,187 | 98,977 (0%) | 0% | - | Common Stock |